8.30am Morning Networking Coffee

8:50 am Chair’s Opening Remarks

• Shayak Samaddar Research Scientist , Eli Lilly

Increasing Tissue Specific Delivery through Optimizing Formulation & Design

9:00 am Non-Viral Delivery of RNA for Gene Therapy & Editing

• Daniel Anderson Professor , MIT

9:30 am Panel Discussion: Modifying RNA Payload Formulations to Increase Stability during Delivery

• AJ Bergman Chief Executive Officer , Capricor Therapeutics
• Xiaoyong Lu Director of Chemistry & Oligonucleotide Delivery , Sirnaomics
• John Lewis Chief Executive Officer , Entos Pharmaceuticals
• Ashish Sarode Associate Director Delivery & Formulation, Sanofi

10.30am Morning Networking Break

Achieving Targeted RNA Delivery with Next Generation Non-Viral Systems

11:30 am Exploring a Next-Generation Delivery Platform for Targeted Payload Delivery:
Fusogenix Proteolipid Vehicle (PLV)

• John Lewis Chief Executive Officer , Entos Pharmaceuticals

12:00 pm Inhalable Lipid Nanoparticles for Messenger RNA Therapeutics

• Jeonghwan Kim Postdoctoral Scholar , Oregon State University

12.30am Networking Lunch

Engineering, Formulation & Packaging Methods for Non-Viral RNA Delivery Systems

1:30 pm Engineering Extracellular Vesicles for the Delivery of Gene Editing Tools

• Alena Ivanova Postdoctoral Fellow , AstraZeneca

2:00 pm RNA Packaging & Delivery via ARMMs (ARrestin-Domain 1 Mediated Microvesicles) Technology

• Nelly Valkov Scientist II , Vesigen Therapeutics

2:30 pm Engineer Exosome for Drug Delivery

• Olga Villamizar Principal Scientist , Pfizer

3:00 pm Chair’s Closing Remarks

• Shayak Samaddar Research Scientist , Eli Lilly

End of Non-Viral RNA Delivery Systems Summit